BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 22, 2004
View Archived Issues
Results of first phase III multicenter study of naltrexone depot formulation
Read More
Update on fosamprenavir in HIV infection
Read More
Preliminary data suggest tipranavir is safe in heavily pretreated HIV-infected patients
Read More
Conclusion of phase II study of Liprostin for PVD
Read More
Oscient updates status of leading programs
Read More
FDA extends Fosrenol review
Read More
Eligard six-month product submitted for approval in Canada
Read More
Depomed submits Proquin XR NDA
Read More
NeuroSearch initiates phase II studies of NS-1209 for refractory status epilepticus
Read More
Enrollment completed for Fibrostat phase IIb study
Read More
Enrollment underway in PRIMO-CABG-2 study of pexelizumab
Read More
Agreement on phase III program for eculizumab for PNH
Read More
AGY Therapeutics licenses sigma receptor agonist compound from M's Science
Read More
IND active for phase I/II study of TG-100-115
Read More
Osel advances Lactin-V into clinical testing
Read More
FDA clearance for clinical study of Alferon N in relapsing-remitting MS
Read More
Second phase I study planned for CTI-01
Read More
Novel antiinflammatory agents trigger apoptosis in cancer cell lines
Read More
Sankyo claims immunosuppressive agents
Read More
Teva discloses compounds for neurological disorders
Read More
YAK3 inhibitors for hematopoietic diseases
Read More
Antibacterial agents in early development at GSK
Read More
Mixed lineage kinase modulators described in a patent
Read More
Agonistic effects described for TAK-559 on different human PPAR subtypes
Read More
Clinical improvements found with oxandrolone in HAE
Read More